methylprednisolone has been researched along with Community Acquired Infection in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Anzueto, A; Bell, WA; Bridges, L; Buck, T; Davis-Karim, A; El-Solh, A; Guardiola, JJ; Huang, GD; Johnson, DP; Lan, C; Lin, J; Martin, TJ; Meduri, GU; Nielsen, L; Restrepo, MI; Seam, N; Shih, MC; Sriram, P; Suffredini, A; Umberger, R; Uyeda, L; Zhao, L | 1 |
| Chang, JH; Hsu, CW; Hsu, SC; Hsu, YP; Huang, SK; Huang, WC; Liu, CT | 1 |
| Agusti, C; Ceccato, A; Cilloniz, C; Ferrer, M; Gabarrus, A; Menendez, R; Niederman, MS; Ranzani, OT; Sibila, O; Torres, A | 1 |
| Guo, J; Huang, J; Huang, W; Li, H; Zhang, T | 1 |
| Agustí, C; Anzueto, A; Ferrer, M; Gabarrús, A; Menendez, R; Mensa, J; Niederman, MS; Polverino, E; Restrepo, MI; Sellarés, J; Sibila, O; Torres, A | 1 |
| Carratalà, J; Corominas, M; Dorca, J; Fernández-Agüera, A; Fernández-Sabé, N; Fernández-Serrano, S; Garcia-Vidal, C; Gudiol, F; Manresa, F; Padrones, S | 1 |
| Póvoa, P; Salluh, JI; Soares, M | 1 |
| Confalonieri, M; Golden, E; Meduri, GU; Nawab, QU; Umberger, R | 1 |
| Jean-Pierre, H; Laurens, C; Marouzé, N | 1 |
| Balla, G; Bene, Z; Gaspar, I; Nagy, B; Papp, A; Voko, Z | 1 |
| Alvarez-Sala-Walther, LA; Bellón-Cano, JM; de Miguel-Díez, J; Del Castillo-Rueda, A; Fernández-Herranz, J; Jiménez-García, R | 1 |
| Mok, CC; Ying, KY | 1 |
| Capelli, B; Cerutti, B; Domenighetti, G; Duchini, F; Lepori, M; Perren, A; Senn, V | 1 |
1 review(s) available for methylprednisolone and Community Acquired Infection
| Article | Year |
|---|---|
Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia: A systematic review and meta-analysis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Community-Acquired Infections; Humans; Hydrocortisone; Intensive Care Units; Length of Stay; Methylprednisolone; Middle Aged; Mortality; Pneumonia; Prednisolone; Randomized Controlled Trials as Topic; Respiration, Artificial; Severity of Illness Index; Treatment Outcome | 2019 |
8 trial(s) available for methylprednisolone and Community Acquired Infection
| Article | Year |
|---|---|
Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia.
Topics: Adult; Community-Acquired Infections; Critical Illness; Humans; Methylprednisolone; Pneumonia; Respiration, Artificial; Treatment Outcome | 2022 |
Sphingosine-1-phosphate as an indicator for deciding the use of adjuvant corticosteroids therapy in community-acquired pneumonia (sphingosine-1-phosphate and pneumonia trial): Study protocol for a randomized, placebo-controlled trial.
Topics: Adjuvants, Pharmaceutic; Adult; Biomarkers; Clinical Protocols; Community-Acquired Infections; Double-Blind Method; Female; Glucocorticoids; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Lysophospholipids; Male; Methylprednisolone; Pneumonia; Sphingosine | 2019 |
Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Macrolides; Male; Methylprednisolone; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 2017 |
Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Community-Acquired Infections; Cytokines; Double-Blind Method; Female; Hospital Mortality; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Methylprednisolone; Middle Aged; Pneumonia; Respiratory Insufficiency; Shock; Treatment Failure | 2015 |
Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial.
Topics: Aged; Community-Acquired Infections; Double-Blind Method; Female; Follow-Up Studies; Humans; Legionnaires' Disease; Male; Methylprednisolone; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Streptococcal Infections; Treatment Outcome | 2011 |
Efficacy of methylprednisolone in children with severe community acquired pneumonia.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; C-Reactive Protein; Child; Child, Preschool; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Length of Stay; Leukocyte Count; Male; Methylprednisolone; Pneumonia; Severity of Illness Index; Time Factors; Treatment Outcome | 2013 |
[Influence of systemic corticosteroid administration in the prognosis of patients with community-acquired pneumonia].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Community-Acquired Infections; Female; Follow-Up Studies; Hospital Mortality; Humans; Length of Stay; Logistic Models; Male; Methylprednisolone; Middle Aged; Multivariate Analysis; Patient Readmission; Pneumonia; Pregnenediones; Prospective Studies; Treatment Outcome; Young Adult | 2012 |
Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Methylprednisolone; Middle Aged; Pilot Projects; Pneumococcal Infections; Pneumonia; Prednisone; Protein Precursors; Pulmonary Disease, Chronic Obstructive | 2008 |
4 other study(ies) available for methylprednisolone and Community Acquired Infection
| Article | Year |
|---|---|
Corticosteroids in severe community-acquired pneumonia: the path we choose depends on where we want to get.
Topics: Adrenal Cortex Hormones; Community-Acquired Infections; Evidence-Based Medicine; Humans; Methylprednisolone; Pneumonia; Therapeutic Equipoise | 2011 |
Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement.
Topics: Adrenal Cortex Hormones; C-Reactive Protein; Community-Acquired Infections; Humans; Inflammation; Methylprednisolone; Outcome Assessment, Health Care; Pneumonia; Randomized Controlled Trials as Topic | 2011 |
[Staphylococcus pseudintermedius and Pasteurella dagmatis associated in a case of community-acquired pneumonia].
Topics: Adrenal Gland Neoplasms; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Small Cell; Cats; Combined Modality Therapy; Community-Acquired Infections; Cranial Irradiation; Humans; Immunocompromised Host; Liver Neoplasms; Male; Methylprednisolone; Pasteurella; Pasteurella Infections; Pets; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Species Specificity; Staphylococcus | 2012 |
Lupus pneumonitis or severe acute respiratory syndrome?
Topics: Adult; Antiviral Agents; China; Community-Acquired Infections; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Middle Aged; Ofloxacin; Pneumonia; Ribavirin; Severe Acute Respiratory Syndrome; Treatment Outcome | 2004 |